. Author manuscript; available in PMC: 2013 Feb 3.

Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 May 19;31(8):1916–1926. doi: 10.1161/ATVBAHA.111.226365

Table 1.

Baseline Clinical Characteristics of HLP-HTG Patients and Controls

	All HTG	HLP Type 5	HLP Type 4	HLP Type 3	HLP Type 2B	Controls
No.	504	180	128	37	159	1213
Females, %	32.4	29.4	22.7	37.8	42.1	42.0
Diabetes, %	26.4	31.7	29.7	24.3	18.2	0.3
Age, y	51.7 ± 12.7	49.6 ± 11.7	53.0 ± 13.4	51.4 ± 12.7	53.2 ± 13.1	48.2 ± 10.8
BMI, kg/m²	30.0 ± 4.9	30.6 ± 4.9	30.5 ± 5.9	28.9 ± 2.5	29.3 ± 4.3	26.4 ± 4.4
TC, mmol/L	8.2 ± 3.8	10.8 ± 5.1	5.1 ± 1	9.4 ± 1.8	7.9 ± 1.5	5.1 ± 0.9
HDL-C, mmol/L	0.9 ± 0.3	0.8 ± 0.3	0.8 ± 0.3	1.0 ± 0.3	1.1 ± 0.3	1.4 ± 0.4
TG, mmol/L	13.6 ± 18.2	28.3 ± 24.3	5.4 ± 1.9	7.0 ± 3.9	5.3 ± 1.9	1.1 ± 0.4

HTG blood sampling was performed in a fasting state (12 h); control blood sampling was performed in a fasting or semifasting (4 h) state. Values are mean ± SD. BMI indicates body mass index; TC, total cholesterol.